News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
313,655 Results
Type
Article (11877)
Company Profile (76)
Press Release (301694)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (97784)
Career Advice (318)
Deals (16738)
Drug Delivery (98)
Drug Development (29542)
Employer Resources (54)
FDA (7618)
Job Trends (7113)
News (138970)
Policy (11318)
Tag
2025 Best Places to Work (12)
2026 Best Places to Work (18)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
40 Under 40 (1)
Academia (987)
Academic (1)
Accelerated approval (39)
ADA (21)
Adcomms (1)
Allergies (117)
Alliances (23905)
ALS (118)
Alzheimer's disease (914)
Antibody-drug conjugate (ADC) (498)
Approvals (8529)
Artificial intelligence (538)
ASCO (173)
Autoimmune disease (280)
Automation (62)
Bankruptcy (82)
Belgium (29)
Best Places to Work (6145)
BIO (43)
Biologics (61)
BIOSECURE Act (11)
Biosimilars (215)
BioSpace Insights (98)
Biotechnology (38)
Bispecific (50)
Bladder cancer (148)
Brain cancer (31)
Breast cancer (501)
Cancer (4042)
Cardiovascular disease (363)
Career advice (300)
Career pathing (14)
CAR-T (191)
CDC (10)
CDMO (132)
Celiac Disease (6)
Cell-line development (1)
Cell therapy (567)
Cervical cancer (41)
Clinical research (29586)
Collaboration (1868)
Commercialization (55)
Company closure (1)
Compensation (679)
Complete response letters (43)
COVID-19 (1421)
CRISPR (73)
CRO (8)
C-suite (1051)
Cystic fibrosis (71)
Data (5841)
Decentralized trials (1)
Denatured (33)
Depression (81)
Dermatology (141)
Diabetes (428)
Diagnostics (3794)
Digital health (52)
Diversity (5)
Diversity, equity & inclusion (15)
Drug discovery (267)
Drug pricing (48)
Drug shortages (16)
Duchenne muscular dystrophy (159)
Earnings (33390)
Editorial (19)
Employer branding (10)
Employer resources (50)
ESMO (252)
Events (52839)
Executive appointments (845)
Eye disease (10)
FDA (10696)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (1)
Friedreich's ataxia (8)
Frontotemporal dementia (15)
Funding (1159)
Gene editing (140)
Generative AI (49)
Gene therapy (414)
GLP-1 (583)
Government (1497)
Grass and pollen (5)
Guidances (277)
Healthcare (8571)
Hematology (121)
HIV (93)
Huntington's disease (31)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (108)
Immunology and inflammation (146)
Immuno-oncology (89)
Indications (222)
Infectious disease (1701)
Inflammatory bowel disease (146)
Inflation Reduction Act (1)
Influenza (107)
Intellectual property (234)
Interviews (42)
IPO (7695)
IRA (11)
Job creations (1266)
Job search strategy (258)
JPM (26)
Kidney cancer (21)
Kidney disease (103)
Labor market (48)
Layoffs (202)
Leadership (13)
Legal (1894)
Licensing (105)
Liver cancer (60)
Longevity (25)
Lung cancer (688)
Lung diease (15)
Lymphoma (320)
Machine learning (31)
Management (16)
Manufacturing (1034)
Marketing (37)
MASH (148)
Medical affairs (4)
Medical device (7250)
Medtech (7398)
Melanoma (73)
Mergers & acquisitions (10065)
Metabolic disorders (996)
Middle East (2)
mRNA (143)
Multiple sclerosis (129)
Multispecific (3)
NASH (12)
Netherlands (35)
Neurodegenerative disease (259)
Neuropsychiatric disorders (38)
Neuroscience (1874)
Neurotech (2)
NextGen: Class of 2026 (1914)
Non-profit (1811)
Now hiring (33)
Obesity (408)
Opinion (100)
Ovarian cancer (117)
Pain (137)
Pancreatic cancer (207)
Parkinson's disease (218)
Partnered (24)
Patents (418)
Patient advocacy (3)
Patient recruitment (527)
Patient selection (66)
Peanut (37)
People (30246)
Peptides (19)
Pharmaceutical (23)
Pharmacy benefit managers (5)
Phase 1 (7023)
Phase 2 (11773)
Phase 3 (12932)
Pipeline (8886)
Policy (102)
Postmarket research (995)
Preclinical (2125)
Press Release (55)
Prostate cancer (227)
Psychedelics (14)
Radioligand (2)
Radiopharmaceuticals (246)
Rare diseases (687)
Real estate (2857)
Recruiting (24)
Regenerative medicine (15)
Regulatory (11973)
Reports (30)
Research institute (1085)
Resumes & cover letters (38)
Rett syndrome (26)
RNA editing (10)
RSV (62)
Saudi Arabia (1)
Schizophrenia (120)
Series A (200)
Series B (150)
Service/supplier (3)
Sickle cell disease (81)
Special edition (7)
Spinal muscular atrophy (114)
Sponsored (34)
Startups (1279)
Stem cells (3)
Stomach cancer (14)
Substance use disorders (8)
Supply chain (102)
Switzerland (17)
Tariffs (29)
Tax incentives (1)
The Weekly (17)
Vaccines (746)
Venture capital (60)
Weight loss (228)
Wet AMD (4)
Women's health (100)
Worklife (6)
Date
Today (27)
Last 7 days (351)
Last 30 days (2061)
Last 365 days (17709)
2026 (16356)
2025 (16673)
2024 (18138)
2023 (20028)
2022 (29046)
2021 (30824)
2020 (28648)
2019 (20921)
2018 (15748)
2017 (14336)
2016 (13424)
2015 (15177)
2014 (10909)
2013 (8755)
2012 (9411)
2011 (8985)
2010 (7736)
Location
Africa (346)
Alabama (33)
Alaska (4)
Arizona (124)
Arkansas (8)
Asia (24747)
Australia (3920)
California (8284)
Canada (2276)
China (1754)
Colorado (299)
Connecticut (368)
Delaware (348)
Europe (51813)
Florida (1237)
Georgia (283)
Hawaii (4)
Idaho (18)
Illinois (721)
India (142)
Indiana (546)
Iowa (16)
Japan (692)
Kansas (58)
Kentucky (18)
Louisiana (19)
Maine (38)
Maryland (960)
Massachusetts (6515)
Michigan (304)
Minnesota (416)
Mississippi (3)
Missouri (121)
Montana (16)
Nebraska (10)
Nevada (106)
New Hampshire (62)
New Jersey (2813)
New Mexico (17)
New York (2315)
North Carolina (1211)
North Dakota (12)
Northern California (4312)
Ohio (302)
Oklahoma (9)
Oregon (15)
Pennsylvania (1731)
Puerto Rico (21)
Rhode Island (29)
South America (490)
South Carolina (30)
Southern California (3321)
Tennessee (126)
Texas (1072)
United States (30547)
Utah (178)
Virginia (196)
Washington D.C. (41)
Washington State (652)
West Virginia (2)
Wisconsin (114)
Wyoming (2)
313,655 Results for "djo global".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PharmaBlock Convenes Global CMC Experts to Advance Smarter Drug Development Decisions
Lifecycle-based CMC strategies can help biotech companies balance speed, risk and long-term asset value as programs advance globally
November 9, 2026
·
1 min read
Press Releases
Vetter expands global manufacturing network to support future customer needs
Strategic investments strengthen resilience and service capabilities for innovative injectable therapies · First of ten additional commercial manufacturing lines already operational · Continued expansion of global filling capabilities · Ongoing investments strengthen flexibility, resilience, and supply security
September 29, 2026
·
1 min read
Press Releases
NovAccel Expands U.S. Presence to Advance Global Actinium-225 Supply
· New U.S. subsidiary, NovAccel Isotopes Inc., established to support North American growth and long-term global supply ambitions in Ac-225 · Arnaud Lesegretain appointed Director and Chief Commercial and Business Officer of NovAccel, Inc., and CEO of NovAccel Isotopes Inc.; Takashi Mizukami appointed Director and Chief Strategy Officer
September 21, 2026
·
1 min read
Press Releases
TempraMed Granted U.S. Patent for Pen Agnostic, VIVI Cap Smart(TM) Further Strengthens Global Intellectual Property Position
Patent Grant in the U.S. marks a major milestone in global IP strategy, advancing protection of its VIVI Cap Smart(TM) platform Highlights U.S. patent officially granted by the U.S. Patent Office on September 29, 2026 Covers core innovations underpinning TempraMed’s VIVI Cap Smart™, which was launched earlier this year Strengthens the Company’s global intellectual property position with 39 granted patents and registered designs across multiple jurisdictions, in addition to pending patent and design applications TempraMed portfolio now available across McKesson Medical-Surgical’s U.S. B2B network, including Optum Now, physician offices, long-term care and home health, under an expanded agreement signed in June 2026 Online B2C distribution in the U.S. through Amazon, and Walmart
November 10, 2026
·
5 min read
Press Releases
Leads Biolabs Presents Opamtistomig (PD-L1/4-1BB Bispecific Antibody) to Global Investors at the 2026 Jefferies Global Healthcare Conference
November 20, 2026
·
15 min read
Insights
Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand
A surge of consolidation, rising appetite for specialized manufacturing and a shift toward decentralized trials is reshaping Switzerland’s life sciences landscape. From peptide producers to organoid CROs, service providers are scaling and diversifying as global sponsors turn to Swiss hubs for talent, innovation and regulatory strength.
October 5, 2026
·
6 min read
·
Jennifer C. Smith-Parker
Press Releases
Amlogenyx to Participate in 2026 Jefferies Global Healthcare Conference
November 11, 2026
·
1 min read
Press Releases
Labcorp to Speak at the UBS Global Healthcare Conference
November 4, 2026
·
1 min read
Press Releases
Kiora Pharmaceuticals Appoints Keith J. Lane as Executive Vice President of Global Clinical Development and Regulatory Affairs
Clinical development executive brings over 20 years of ophthalmology experience supporting U.S. and global clinical trials to support the advancement of Kiora’s pipeline and new asset opportunities
September 8, 2026
·
2 min read
Press Releases
eGenesis to Participate in the Jefferies Global Healthcare Conference 2026
November 10, 2026
·
1 min read
1 of 31,366
Next